바로가기메뉴

본문 바로가기 주메뉴 바로가기

logo

ISSN : 3022-6805

Article Contents

Prev
e-Submission

Vol.4 No.1

Citation Share

Therapeutic potential of traditionally used medicinal plant Andrographis paniculata (Burm. F.) against diabesity: An experimental study in rats

CELLMED / CELLMED, (P)3022-6805; (E)3022-6791
2014, v.4 no.1, pp.7-7
https://doi.org/10.5667/tang.2014.0001
Ajit Kumar Thakur (Banaras Hindu University)
Shyam Sunder Chatterjee (Stettiner Straße 1)
Vikas Kumar (Banaras Hindu University)
Ajit, K. T. , Shyam, S. C. , & Vikas, K. (2014). Therapeutic potential of traditionally used medicinal plant Andrographis paniculata (Burm. F.) against diabesity: An experimental study in rats. CELLMED, 4(1), 7-7, https://doi.org/10.5667/tang.2014.0001

Abstract

Metabolic effects of ten daily doses of standardized extract of Andrographis paniculata leaves (AP) rich in andrographolide were evaluated in a rat model of type-2 diabetes and in diet induced obese rats. AP was administered per-orally as suspension in 0.3% carboxymethylcellulose at doses of 50, 100 and 200 mg/kg/day for 10 consecutive days. Blood glucose, insulin and lipid profile of rats were measured by using enzyme kits. In addition, effects of such treatments on anti-oxidant enzymes activity and histopathological changes in various organs of diabetic rats were assessed. AP treatments reversed body weight losses and increased plasma insulin level in diabetic rats. The anti-oxidant enzymes activity became normal and histopathological changes observed in pancreas, liver, kidney and spleen of diabetic animals were less severe in extract treated groups. On the other hand, hyperinsulinemia and increased body weight gains observed in high fat or fructose fed rats were less severe in the extract treated groups. These observations revealed therapeutic potentials of the extract for treatments of diabesity associated metabolic disorders, and suggest that the effects of the extract on insulin homeostasis depend on the metabolic status of animals. Activation of cytoprotective mechanisms could be involved in its mode of action.

keywords
diabetes, obesity, insulin homeostasis, oxidative damage, organ pathologies

Reference

1.

Agarwal R, Sulaiman SA, Mohamed M. Open label clinical trial to study adverse effects and tolerance to dry powder of the aerial part of Andrographis paniculata in patients type 2 with diabetes mellitus. Malays J Med Sci. 2005;12:13-19.

2.

Al-Bayaty FH, Abdulla MA, Abu Hassan MI, Ali HM. Effect of Andrographis paniculata leaf extract on wound healing in rats. Nat Prod Res. 2012;26:423-429

3.

Beeler JA, Frazier CR, Zhuang X. Putting desire on a budget: dopamine and energy expenditure, reconciling reward and resources. Front Integr Neurosci. 2012;6:49.

4.

Bensky D, Gamble A. Andrographis paniculata: Chinese Herbal Medicine Materia Medica. (Washington, USA: Eastland Press), 1986.

5.

Braun J, Bopp M, Faeh D. Blood glucose may be an alternative to cholesterol in CVD risk prediction charts. Cardiovasc Diabetol. 2013;12:24.

6.

Burgos RA, Hancke JL, Bertoglio JC, Aguirre V, Arriagada S, Calvo M, Cáceres DD. Efficacy of an Andrographis paniculata composition for the relief of rheumatoid arthritis symptoms: a prospective randomized placebo-controlled trial. Clin Rheumatol. 2009;28:931-946.

7.

Chandrasekaran CV, Gupta A, Agarwal A. Effect of an extract of Andrographis paniculata leaves on inflammatory and allergic mediators in vitro. J Ethnopharmacol. 2010;129:203-207.

8.

Chandrasekaran CV, Thiyagarajan P, Deepak HB, Agarwal A. In vitro modulation of LPS/calcimycin induced inflammatory and allergic mediators by pure compounds of Andrographis paniculata (King of bitters) extract. Int Immunopharmacol. 2011;11:79-84.

9.

Chandrasekaran CV, Thiyagarajan P, Sundarajan K, Goudar KS, Deepak M, Murali B, Allan JJ, Agarwal A. Evaluation of the genotoxic potential and acute oral toxicity of standardized extract of Andrographis paniculata (KalmCold). Food Chem Toxicol. 2009;47:1892-1902.

10.

Chao WW, Lin BF. Isolation and identification of bioactive compounds in Andrographis paniculata (Chuanxinlian). Chin Med. 2010;5:17.

11.

Chatterjee SS, Kumar V. Holistic psychopharmacology and promiscuous plants and principles of Ayurveda. Am J Plant Sci. 2012;3:1015-1021.

12.

Colagiuri S. Diabesity: therapeutic options. Diabetes Obes Metab. 2010;12:463-473.

13.

du Vigneaud V, Karr WG. Carbohydrate utilization: I. Rate of disappearance of d-glucose from the blood. J Biol Chem. 1925;66:281-300.

14.

Farag YM, Gaballa MR. Diabesity: an overview of a rising epidemic. Nephrol Dial Transplant. 2011;26:28-35.

15.

Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499-502.

16.

Govindarajan R, Vijayakumar M, Pushpangadan P. Antioxidant approach to disease management and the role of 'Rasayana' herbs of Ayurveda. J Ethnopharmacol. 2005;99:165-178.

17.

Husain GM, Chatterjee SS, Singh PN, Kumar V. Hypolipidemic and antiobesity-like activity of standardised extract of Hypericum perforatum L. in Rats. ISRN Pharmacol. 2011a; 2011: 505247.

18.

Husain GM, Singh PN, Singh RK, et al. Antidiabetic activity of standardized extract of Quassia amara in nicotinamide-streptozotocin-induced diabetic rats. Phytother Res. 2011b;25:1806-1812.

19.

Jalal R, Bagheri SM, Moghimi A, Rasuli MB. Hypoglycemic effect of aqueous shallot and garlic extracts in rats with fructose-induced insulin resistance. J Clin Biochem Nutr. 2007;41:218-223.

20.

Kakkar P, Das B, Viswanathan PN. A modified spectrophotometric assay of superoxide dismutase. Indian J Biochem Biophys. 1984;21:130-132.

21.

Lim JC, Chan TK, Ng DS, Sagineedu SR, Stanslas J, Wong WS. Andrographolide and its analogues: versatile bioactive molecules for combating inflammation and cancer. Clin Exp Pharmacol Physiol. 2012;39:300-310.

22.

Luck H. Methods of enzymatic analysis. In, Bergmeyer HU ed. (Verlag Chemie, Weinheim and New York, USA: Academic Press), pp. 885-888, 1963.

23.

Masiello P, Broca C, Gross R, Roye M, Manteghetti M, Hillaire-Buys D, Novelli M, Ribes G. Experimental NIDDM: development of a new model in adult rats administered streptozotocin and nicotinamide. Diabetes. 1998;47:224-229.

24.

Mishra K, Dash AP, Swain BK, Dey N. Anti-malarial activities of Andrographis paniculata and Hedyotis corymbosa extracts and their combination with curcumin. Malar J. 2009;8:26.

25.

Nugroho AE, Andrie M, Warditiani NK, Siswanto E, Pramono S, Lukitaningsih E. Antidiabetic and antihiperlipidemic effect of Andrographis paniculata (Burm. f.) Nees and andrographolide in high-fructose-fat-fed rats. Indian J Pharmacol. 2012;44:377-381.

26.

Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 1979;95:351-358.

27.

Shen T, Yang WS, Yi YS, Sung GH, Rhee MH, Poo H, Kim MY, Kim KW, Kim JH, Cho JY. AP-1/IRF-3 Targeted Anti-Inflammatory Activity of Andrographolide Isolated from Andrographis paniculata. Evid Based Complement Alternat Med. 2013;2013:210736.

28.

Sims EA, Danforth E Jr, Horton ES, Bray GA, Glennon JA, Salans LB. Endocrine and metabolic effects of experimental obesity in man. Recent Prog Horm Res. 1973;29:457-496.

29.

Srinivasan K, Viswanad B, Asrat L, Kaul CL, Ramarao P. Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening. Pharmacol Res. 2005;52:313-320.

30.

Subramanian R, Zaini Asmawi M, Sadikun A. A bitter plant with a sweet future? A comprehensive review of an oriental medicinal plant: Andrographis paniculata. Phytochemistry Rev. 2012;11:39-75.

31.

Subramanian R, Zaini Asmawi M, Sadikun A. Effect of ethanolic extract of Andrographis paniculata (Burm. F.) Nees on a combination of fat-fed and low dose streptozotocin induced chronic insulin resistance in rats. Diabetol Croat. 2008;37:13-22.

32.

Thakur AK, Chatterjee SS, Kumar V. Neuropsychopharmacology of a therapeutically used Andrographis paniculata extract: a preclinical study. Oriental Pharm Exp Med. 2013. doi: 10.1007/s13596-013-0140-4.

33.

Thakur M, Weng A, Fuchs H, Sharma V, Bhargava CS, Chauhan NS, Dixitc VK, Bhargava S. Rasayana properties of Ayurvedic herbs: Are polysaccharides a major contributor. Carbohydr Polymers. 2012;87:3-15.

34.

van Reedt Dortland AK, Giltay EJ, van Veen T, Zitman FG, Penninx BW. Longitudinal relationship of depressive and anxiety symptoms with dyslipidemia and abdominal obesity. Psychosom Med. 2013a;75:83-89.

35.

van Reedt Dortland AK, Vreeburg SA, Giltay EJ, Licht CM, Vogelzangs N, van Veen T, de Geus EJ, Penninx BW, Zitman FG. The impact of stress systems and lifestyle on dyslipidemia and obesity in anxiety and depression. Psychoneuroendocrinology. 2013b;38:209-218.

36.

Wu KK, Huan Y. Streptozotocin-induced diabetic models in mice and rats. Curr Protoc Pharmacol. 2008;5:47.

37.

Xu J, Li Z, Cao M, Zhang H, Sun J, Zhao J, Zhou Q, Wu Z, Yang L. Synergetic effect of Andrographis paniculata polysaccharide on diabetic nephropathy with andrographolide. Int J Biol Macromol. 2012;51:738-742.

38.

Yang T, Shi HX, Wang ZT, Wang CH. Hypolipidemic effects of andrographolide and neoandrographolide in mice and rats. Phytother Res. 2013;27:618-623.

39.

Yu BC, Hung CR, Chen WC, Cheng JT. Antihyperglycemic effect of andrographolide in streptozotocin-induced diabetic rats. Planta Med. 2003;69:1075-1079.

40.

Zhang XF, Tan BK. Anti-diabetic property of ethanolic extract of Andrographis paniculata in streptozotocin-diabetic rats. Acta Pharmacol Sin. 2000a;21:1157-1164.

41.

Zhang XF, Tan BK. Antihyperglycaemic and anti-oxidant properties of Andrographis paniculata in normal and diabetic rats. Clin Exp Pharmacol Physiol. 2000b;27:358-363.

CELLMED

e-Submission OA Policy